Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 23 October

Grady Wulff
October 23, 2023

Weekly Wrap 20 October

Grady Wulff
October 20, 2023

Morning Bell 20 October

Sam Kanaan
October 20, 2023

Morning Bell 19 October

Grady Wulff
October 19, 2023

Morning Bell 18 October

Grady Wulff
October 18, 2023

Morning Bell 17 October

Sam Kanaan
October 17, 2023

Morning Bell 16 October

Grady Wulff
October 16, 2023

Weekly Wrap 13 October

Grady Wulff
October 13, 2023

Morning Bell 13 October

Sam Kanaan
October 13, 2023

Morning Bell 12 October

Grady Wulff
October 12, 2023

Morning Bell 11 October

Grady Wulff
October 11, 2023

Morning Bell 10 October

Sam Kanaan
October 10, 2023